travel medicine lshtm

Accessibility tools

• Increase text size
• Decrease text size
• Reset text size
• Black and white
• Blue contrast
• Beige contrast
• High contrast
• Reset contrast
• Work with us

Dr Nicky Longley

• 020 3447 9761
• n. longley @nhs.net
• Hospital for Tropical Diseases

GMC/GDC number:

Professional background.

Consultant in infectious diseases and travel medicine at The Hospital for Tropical Diseases at UCLH.

Associate professor in travel medicine at London School of Hygiene and Tropical Medicine. Member of ; the faculty of Travel medicine RCPSG, the International Expert Committee for Travel Medicine and TAG for NaTHNaC. Trained in London, Uganda and South Africa . Runs the short course in travel medicine and teaches the travel medicine component of the DTM&H at LSHTM.

Specialties

• Infectious and Tropical Diseases
• Infection Inpatients
• Travel clinic services
• HTD Outpatient services
• RESPOND integrated refugee health service

Research interests

The immunosuppressed traveller, late stage HIV and cryptococcosis

Publications

Influenza vaccination and interruption of methotrexate in rheumatoid arthritis in the COVID-19 era: an ongoing dilemma: Lancet Rheumatology accepted for publication. The emerging spectrum of COVID-19 neurology: clinical, radiological and laboratory findings. Paterson RW, Brown RL, Benjamin L, Nortley R, Wiethoff S, Bharucha T, Jayaseelan DL, Kumar G, Raftopoulos RE, Zambreanu L, Vivekanandam V, Khoo A, Geraldes R, Chinthapalli K, Boyd E, Tuzlali H, Price G, Christofi G, Morrow J, McNamara P, McLoughlin B, Lim ST, Mehta PR, Levee V, Keddie S, Yong W, Trip SA, Foulkes AJM, Hotton G, Miller TD, Everitt AD, Carswell C, Davies NWS, Yoong M, Attwell D, Sreedharan J, Silber E, Schott JM, Chandratheva A, Perry RJ, Simister R, Checkley A, Longley N, Farmer SF, Carletti F, Houlihan C, Thom M, Lunn MP, Spillane J, Howard R, Vincent A, Werring DJ, Hoskote C, Jäger HR, Manji H, Zandi MS. Brain. 2020 Oct 1;143(10):3104-3120. doi: 10.1093/brain/awaa240. 2020 Jul 31;20(1):555. doi: 10.1186/s12879-020-05227-9. Determine TB-LAM point-of-care tuberculosis assay predicts poor outcomes in outpatients during their first year of antiretroviral therapy in South Africa Andrew D Kerkhoff 1 , Nicky Longley 2 3 4 , Nicola Kelly 5 , Anna Cross 5 , Monica Vogt 5 , Robin Wood 5 6 , Sabine Hermans 5 7 , Stephen D Lawn 5 6 , Thomas S Harrison 8 Affiliations PMID: 32736601 PMCID: PMC7393716 DOI: 10.1186/s12879-020-05227-9 Implementation and Operational Research: Evaluation of a Public-Sector, Provider-Initiated Cryptococcal Antigen Screening and Treatment Program, Western Cape, South Africa. Vallabhaneni S, Longley N, Smith M, Smith R, Osler M, Kelly N, Cross A, Boulle A, Meintjes G, Govender NP. J Acquir Immune Defic Syndr. 2016 Jun 1;72(2):e37-e42Cryptococcal Antigen Screening in Patients Initiating ART in South Africa: A Prospective Cohort Study

Longley N, Jarvis JN, Meintjes G, Boulle A, Cross A, Kelly N, Govender NP, Bekker LG, Wood R, Harrison TS. Clin Infect Dis. 2016 Mar 1;62(5):581-587AIDS-related mycoses: the way forward

Brown GD, Meintjes G, Kolls JK, Gray C, Horsnell W; Working Group from the EMBO-AIDS Related Mycoses Workshop, Trends Microbiol. 2014 Mar;22(3):107-9.Determinants of mortality in a combined cohort of 501 patients with HIV-associated Cryptococcal meningitis: implications for improving outcomes

Jarvis JN, Bicanic T, Loyse A, Namarika D, Jackson A, Nussbaum JC, Longley N, Muzoora C, Phulusa J, Taseera K, Kanyembe C, Wilson D, Hosseinipour MC, Brouwer AE, Limmathurotsakul D, White N, van der Horst C, Wood R, Meintjes G, Bradley J, Jaffar S, Harrison T. Clin Infect Dis. 2014 Mar;58(5):736-45Cryptococcal immune reconstitution inflammatory syndrome.

Longley N, Harrison TS, Jarvis JN. Curr Opin Infect Dis. 2013 Feb;26(1):26-34Cryptococcal antigen screening and preemptive therapy in patients initiating antiretroviral therapy in resource-limited settings: a proposed algorithm for clinical implementation

Jarvis JN, Govender N, Chiller T, Park B, Longley N, Meintjes G, Bekker LG, Wood R, Lawn SD, Harrison TS J Int Assoc Physicians AIDS Care (Chic). 2012 Nov-Dec;11(6):374-9Short course amphotericin B with high dose fluconazole for HIV-associated cryptococcal meningitis.

Muzoora CK, Kabanda T, Ortu G, Ssentamu J, Hearn P, Mwesigye J, Longley N, Jarvis JN, Jaffar S, Harrison TS. J Infect. 2012 Jan;64(1):76-81Evaluation of a novel point-of-care cryptococcal antigen test on serum, plasma, and urine from patients with HIV-associated cryptococcal meningitis.

Jarvis JN, Percival A, Bauman S, Pelfrey J, Meintjes G, Williams GN, Longley N, Harrison TS, Kozel TR. Clin Infect Dis. 2011 Nov;53(10):1019-23.Routine cryptococcal antigen screening for HIV-infected patients with low CD4+ T-lymphocyte counts: time to implement in South Africa?

Jarvis JN, Harrison TS, Govender N, Lawn SD, Longley N, Bicanic T, Maartens G, Venter F, Bekker LG, Wood R, Meintjes G. S Afr Med J. 2011 Apr;101(4):232-4.Severe Guillain-Barré syndrome following primary infection with varicella zoster virus in an adult.

Cresswell F, Eadie J, Longley N, Macallan D. Int J Infect Dis. 2010 Feb;14(2):e161-3.Independent association between rate of clearance of infection and clinical outcome of HIV-associated cryptococcal meningitis: analysis of a combined cohort of 262 patients.

Bicanic T, Muzoora C, Brouwer AE, Meintjes G, Longley N, Taseera K, Rebe K, Loyse A, Jarvis J, Bekker LG, Wood R, Limmathurotsakul D, Chierakul W, Stepniewska K, White NJ, Jaffar S, Harrison TS. Clin Infect Dis. 2009 Sep 1;49(5):702-9Dose response effect of high-dose fluconazole for HIV-associated cryptococcal meningitis in southwestern Uganda.

Longley N, Muzoora C, Taseera K, Mwesigye J, Rwebembera J, Chakera A, Wall E, Andia I, Jaffar S, Harrison TS. Clin Infect Dis. 2008 Dec 15;47(12):1556-61

Was this page helpful? Let us know

• {{notification.data.content || ('CLICK_TO_VIEW_NOTIFICATION' | translate) }}
• {{'DISMISS_NOTIFICATIONS_LABEL' | translate }}
• {{ 'PROFILE_BUTTON' | translate }}
• {{ 'REQUESTS_BUTTON' | translate }}
• {{ 'HELP_AND_FAQS' | translate }}
• {{ 'SETTINGS' | translate }}
• {{ 'LOGOUT_BUTTON' | translate }}

Travel Approval & Insurance

Please use this form to request approvals and insurance for LSHTM related Travel. If you have any queries, please contact the ServiceDesk

Get Started

RCPSG Postgraduate Diploma in Travel Medicine

This course has been designed in line with the Faculty of Travel Medicine’s publications 'Good Practice Guidance for Providing a Travel Health Service' and 'Recommendations for the Practice of Travel Medicine'

Reference form

Course Information

The aim of this course is to develop and support healthcare professionals in their role as travel medicine practitioners .

It offers an academic base that assists individuals to become autonomous and reflective practitioners in the delivery of travel medicine services. The course is delivered at postgraduate level and carries 120 credit points at SCQF Level 11.

The content and level of this course facilitates growth and development of cognitive, leadership and practical skills. This will enhance travel medicine practitioners’ practice, by enabling them to make sound judgements and apply best clinical practice or evidence-based theory to support their decision making. This will ultimately support client care, in situations prone to rapid change and subsequently, improve travellers’ health.

If you complete this course, you'll be eligible to join the College as a Member of the Faculty of Travel Medicine (MFTM). You'll also be able to continue your studies to master's level with a MSc Advanced Practice (Travel Medicine) from Glasgow Caledonian University. Details of each of these can be found below.

Course duration and intakes

This course consists of eight postgraduate modules delivered over a period of 12 months . The course will be delivered by specialists in travel medicine using a blended model of two residential elements and online interactive learning.

Students will be expected to attend and contribute to online educational and peer support platforms. Cohort three will begin in May 2025 with a residential week of learning.

The second residential is planned to take place in October 2025 . The residential weeks are mandatory, though we'll consider applications from students requesting online participation.

The Diploma fee is £4,395 and this will include Affiliate Membership of the Faculty of Travel Medicine and access to TRAVAX for the duration of the course.

Once accepted onto the course, a deposit of approximately 10% of the course fee will be due to hold your place. The remaining payment will be made over two further instalments, one due by your start date and the other due six months later. Dates will be provided upon enrolment.

Entry and Language Requirements

Applicants must be able to satisfy the general admission requirements of the Royal College of Physicians and Surgeons of Glasgow.

Academic Requirements

• Applicants must hold a UK bachelor’s degree with honours (2:1 or above) in medicine and surgery, nursing, dentistry, paramedic science or pharmacy or;
• Applicants must hold a UK postgraduate qualification in a health-related subject based on clinical experience or;
• Applicants must hold a bachelor’s degree with honours (2:1 or above) from a recognised international provider of higher education in medicine and surgery, nursing, dentistry, paramedic science or pharmacy or;
• Applicants must hold a postgraduate qualification in a health-related subject based on clinical experience from a recognised international provider of higher education or;
• Applicants must have a record of on-going professional development in their respective field if they don't hold a degree. This record must cover professional development with a significant clinical component from when the applicant began working in their field. This only applies to those who have been practicing without a degree since the year outlined in the table below.

Professional Requirements

• Applicants must hold professional registration with the governing body for their profession in the country which they're resident.
• Applicants must have professional experience in travel medicine practice or aspire to practice in travel medicine when they complete the Postgraduate Diploma in Travel Medicine.

English Language Requirements

Applicants with English as a second language will be assessed for suitability during the application process. English language requirements for this level of study include:

• Overall score 6.0
• No sub-test less than 5.5
• Reading: 17
• Listening: 17
• Speaking: 17
• Writing: 17

Membership of the Royal College of Physicians and Surgeons of Glasgow

Those who successfully complete this course will be eligible to join the College as a Member of the Faculty of Travel Medicine (MFTM) . Non-members starting this course will be offered complimentary Affiliate Membership for one year and access to TRAVAX while studying.

Progression to MSc Advanced Practice (Travel Medicine)

Upon successful completion of the Postgraduate Diploma in Travel Medicine, you'll be eligible to continue your studies to master's level with Glasgow Caledonian University.

You'll be awarded a MSc Advanced Practice (Travel Medicine) if you complete a 60-credit dissertation module over two trimesters in a six-month period. The dissertation would build on the work started in your Postgraduate Diploma. For more information or to sign up, go to the GCU MSc Advanced Practice page .

Module Overview

Epidemiology, Immunology and Travel Risk Assessment

By the end of this module you will have knowledge and understanding of:

• Aspects of epidemiology in relation to the subject of travel medicine.
• Principles of immunology in relation to travel medicine.
• Critical evaluation of the principles underpinning a risk assessment.
• Current key principles of behaviour and the human factors that lead individuals to make decisions which impact their health when abroad.

Non Vector Borne Infections

• The epidemiology, pathophysiology, clinical manifestations and impact of non vector borne infections.
• Effective strategies for prevention of non vector borne infections, including immunisations to maximise protection of at-risk populations.
• The relationship between travellers, host populations and non-vector borne infections and potential implications for travellers in the context of emerging infections.
• Communication of risk assessment and behaviour modification strategies in the preparation of overseas travel, in relation to non vector borne infections.

Vector Borne Infections

• The various disease vectors and how they transmit infection.
• Epidemiology and health implications of vector-borne infections with particular emphasis on malaria and current control approaches to prevent these infections.
• Insect borne infection advice including bite prevention, vaccination where appropriate and in relation to malaria, chemoprophylaxis available and the factors affecting compliance with these measures.
• The principles of diagnosing and treating malaria and other vector borne illnesses and resources that support accurate clinical decision making in relation to prevention and treatment of malaria in travellers.

Environmental Factors and Travel

• The principles of environmental conditions in the context of traveller’s health
• The environmental impact overseas travel has on host communities alongside the travel industry economy.
• Human pathophysiology and physiological effects of flying and the interventions that help prevent illness.
• Risk of trauma to travellers and strategies for prevention.
• Travel insurance and access to medical care overseas.

Research Methods

• Research philosophy.
• Types of research and research approaches.
• The research process, including literature searches, research design and methodology.
• Data management and analyses.

The Complex Traveller - Pre and Post Travel

• Categories of travellers and the complex nature of their special travel requirements.
• Risk factors associated with different categories of travellers and strategies and mechanisms for advising them for overseas travel.
• Management of travellers returning with commonly presented infectious diseases.

Medical Conditions and Travel

• Medical conditions and the potential impact they could have on a traveller’s health.
• Complexities and implications relating to travellers with medical conditions, and current strategies used to prepare them for overseas travel.

Governance, Legal and Ethical Considerations

• The legal implications and ethical aspects that may affect some travellers.
• Differences in legal structures, clinical governance and practice in relation to the delivery a travel medicine services.

RCPSG Postgraduate Diploma in Travel Medicine Application form RCPSG Postgraduate Diploma in Travel Medicine Reference form RCPSG Postgraduate Diploma in Travel Medicine FAQs

• Courses and Conferences
• Examinations
• Qualifications in Travel Medicine
• Good Practice Guidance for Providing a Travel Health Service

Log in to access your Dashboard, book events, pay your subscriptions and access eLearning material.

Register an account

New users must register before logging in. You do not need to be a member of the College in order to register.

Having difficulty registering or logging in? Forgotten your username or password?

• Entertainment
• Submit Your Story

New mpox strain: What is it and what does it mean for the UK?

Experts said the new strain is ‘associated with a more severe disease and higher mortality rates’.

The first case of a new infectious strain of mpox has been detected in Europe after the World Health Organisation (WHO) declared outbreaks in Africa a global emergency.

Experts said the new strain is “associated with a more severe disease and higher mortality rates” than the one that caused the global mpox outbreak in 2022.

– But what is the new strain and what risk does it pose to the UK?

The new strain of mpox is known as clade 1b and it emerged in the Democratic Republic of the Congo (DRC) last year, according to WHO.

The disease is now rapidly spreading to neighbouring countries in Africa, mainly through sexual networks, WHO said, with one case confirmed in Europe.

– Where was the first European case detected?

Swedish health officials announced that there has been one confirmed case of clade 1b on Thursday.

The country’s public health agency said a patient sought healthcare in Stockholm and is understood to have been infected during a visit to Africa.

– What do UK health officials say?

Before the case in Sweden was announced, and following the declaration of clade 1b as a global emergency by the WHO, the UK Health Security Agency (UKHSA) said it was on alert for any cases of the virus.

Officials said there are currently no cases in the UK and the risk to the population is low.

However, the UK is preparing for any potential cases by ensuring clinicians are aware of mpox and able to recognise cases promptly.

Rapid testing is also being made available, while protocols are being developed for the safe care of potential patients to prevent transmission.

– Why has the WHO declared a global emergency?

Mpox was first detected in humans in the DRC in 1970 and is considered endemic to countries in Central and West Africa.

However, WHO said the recent surge of cases in DRC and its spread to neighbouring countries constitutes a public health emergency of international concern (PHEIC) under the International Health Regulations (2005) on Wednesday.

According to WHO, mpox has been reported in DRC for more than 10 years, with the number of cases increasing steadily over the period.

So far in 2024, there have been more than 15,600 cases of mpox and 537 deaths, which the WHO said exceeds last year’s total.

There have also been 100 lab-confirmed cases of clade 1b in four countries neighbouring the DRC that have not reported mpox before: Burundi, Kenya, Rwanda and Uganda.

– Has this happened before?

Yes, it is the second time in two years the WHO has declared mpox a PHEIC.

The first was in 2022 after its rapid spread through sexual contact in countries that had not reported cases before.

The emergency was declared as over in May 2023 following a sustained decline in global cases.

– What do the experts say?

Dr Jonas Albarnaz, a research fellow specialising in pox viruses at the Pirbright Institute, said the case of clade 1b in Sweden “is concerning for two main reasons”.

“First, this is the first clade 1 mpox virus case outside Africa. This indicates that the extent of the international spread of clade 1 outbreak in DRC might be larger than we knew yesterday.

“And second, clade 1 mpox virus is associated with a more severe disease and higher mortality rates than the clade 2 virus responsible for the international mpox outbreak in 2022.”

Michael Marks, a professor of medicine at the London School of Hygiene and Tropical Medicine (LSHTM), said: “It’s clear that this is the largest outbreak of mpox reported from the region.

“It’s also the largest of the clade 1 mpox virus, which has traditionally been associated with a higher case fatality rate than clade 2, which caused the large global outbreak in 2022.”

– How did the UK deal with the last outbreak?

Before the spring of 2022, cases in the UK were usually associated with travel to or from West or Central Africa.

However, in May of that year sustained transmission of the virus was identified in the UK, leading to a large outbreak mostly in men who are gay, bisexual or have sex with other men.

A vaccination programme was launched in the UK in the summer of 2022 and closed the following July.

According to the UKHSA, there were 3,732 confirmed and highly probable mpox cases reported in the UK up to December 31, 2022. In 2023 and up to July 31 this year, 286 cases were reported.

Of these, 269 were in England – with 116 patients presumed to have caught the virus in the UK and 82 outside of the country.

– What are the symptoms of mpox and how does it spread?

Mpox is passed on through close physical contact, including during sexual contact, kissing, cuddling or holding hands.

Symptoms include a high temperature, headache, muscle aches, backache, swollen glands, exhaustion, joint pain and a rash.

Wolverhampton pub in the heart of a community closes doors for last time Plus Food and Drink | Aug 16

Motorcyclist dies after crash with car near Cannock - witnesses urged to contact police Cannock | 3 hours ago

Nostalgia, history and a lot of beer: These are the 10 oldest pubs in the Black Country Food and Drink | 6 hours ago

Gary O'Neil lifts lid on plans for quartet of Wolves attackers Plus Wolves | 20 hours ago

Man arrested on suspicion of attempted murder over Walsall violence that left four men in hospital Crime | 4 hours ago

• Share full article

Advertisement

Supported by

The ‘Orgasm Gap’ Isn’t Going Away for Straight Women

A new study suggests they still have fewer orgasms during sex than men do, even with age and experience.

By Catherine Pearson

Sex researchers and therapists have long known that women in heterosexual relationships tend to have fewer orgasms than men do. A large new study suggests that this “orgasm gap” persists — and does not improve with age.

The Numbers

The research, published recently in the journal Sexual Medicine, found that across all ages, men of all sexual orientations reported higher orgasm rates during sex — from 70 to 85 percent — compared with 46 to 58 percent for women. Lesbian and bisexual women between ages 35 and 49 reported higher orgasm rates than their heterosexual counterparts.

The analysis included data from eight Singles in America surveys, which are funded and conducted by Match.com annually in collaboration with The Kinsey Institute, the sexuality and relationships research program at Indiana University. The sample included more than 24,000 single Americans between the ages of 18 and 100.

Researchers were especially interested in the question of whether orgasm rates vary by age. Amanda Gesselman, a research scientist with the Kinsey Institute and lead author on the study, said she thought the team might find evidence that the orgasm gap narrows as women develop confidence and learn what they like (and, perhaps, their partners develop skills to help pleasure them).

However, while older gay and bisexual men and lesbian women did have higher orgasm rates, “we really didn’t see evidence of closing the orgasm gap overall,” she said, adding that she hopes future studies will explore the age-orgasm connection further.

“We really, as a society, sort of prioritize men’s pleasure and undervalue women’s sexual pleasure,” Dr. Gesselman said. “And I think that contributes to consistent disparities.”

The Limitations

Emily Nagoski, a sex educator and author of the book “Come Together” — who did not work on the new study — said a limitation of the study was that the survey asked: “When having sexual intercourse in general, what percentage of the time do you usually have an orgasm?” But it did not provide a more specific definition of what “sexual intercourse” means.

Research shows the majority of women require some form of clitoral stimulation in order to orgasm. So if straight women defined “sexual intercourse” as vaginal penetration alone, it makes sense that there was a significant gap in orgasm rates, she said.

A more revealing question might be, “What percentage of the sex you have do you like?” Dr. Nagoski said. “Orgasm is not the measure of a sexual encounter. Pleasure is the measure of a sexual encounter.”

Ultimately, what matters is that people spend time figuring out what makes a satisfying sexual encounter for them — which often includes things like connection, trust and comfort, said Kristen Mark, professor at the Eli Coleman Institute for Sexual and Gender Health at the University of Minnesota.

“There are so many ways to experience sexual pleasure, so it’s important not to equate the orgasm gap to a pleasure gap,” she added.

Dr. Mark said that may be especially true later in life, when factors like the hormonal changes that occur during menopause, a partner’s erectile problems or other health challenges can make it difficult for women to reliably orgasm during sex — but they might still be enjoying the sex they are having.

What Progress Looks Like

At the same time that sex researchers and experts are calling for a more nuanced understanding of what makes sex “successful,” they express frustration at the fact that heterosexual women of all ages are still not having as many orgasms as their partners.

Laurie Mintz, a professor of psychology at the University of Florida and author of “Becoming Cliterate: Why Orgasm Equality Matters — and How to Get It,” said the study’s findings underscore the need for comprehensive sex education. But that’s not enough.

Women need to figure out what they find pleasurable, and then feel confident and comfortable communicating that to their partners, Dr. Mintz said. That requires an attitude that conveys “I deserve pleasure as much as my partner,” she added — and it also requires a partner who is receptive and open. Dr. Mintz acknowledged that both are easier said than done, calling the orgasm gap an “insidious” byproduct of patriarchal attitudes toward sex.

Women who are unable to orgasm, or who are simply not having sex that feels good, can talk to their general practitioner, Dr. Mark added — though she lamented that it tends to fall on patients, not medical professionals, to initiate conversations about sexual health. And she acknowledged that most doctors get little if any training in sexual health. Still, “it’s their job to meet you where you are and find you the resources you need,” Dr. Mark said. For instance, issues like dryness and pain during sex after menopause — which can make orgasms elusive — are treatable.

But she and other sexual health experts emphasized that there are larger issues at play. Among them, the lingering idea that women’s sexual pleasure is somehow secondary.

“It can be fixed,” Dr. Mintz said. “It’s going to take education, and empowerment, and acceptance of vibrators and lubricants, and using the word ‘clitoris’ — and all of that.”

Catherine Pearson is a Times reporter who writes about families and relationships. More about Catherine Pearson

What to Know About Your Sexual Health

Sexual health can be an important part of personal well-being. the information below can help you demystify this often misunderstood topic..

A new study suggests women in heterosexual relationships still have fewer orgasms  during sex than men do, even with age and experience, creating an “orgasm gap.”

A common antibiotic, doxycycline, greatly reduced cases of syphilis, gonorrhea and chlamydia when taken every day , a study found.

More than half of men over 40 will experience some kind of erectile problem, and the prevalence increases with age (though men in their 20s and 30s can be affected, too). Here’s what to do about it .

Older daters are not getting adequate screening and protection from S.T.I.s. Here’s how to be a safer sexually active senior .

Any physical activity can improve your sexual health. But these five exercises  are especially beneficial.

New regimens in development, including once-weekly pills and semiannual shots , could help control H.I.V. in hard-to-reach populations.

Phone Numbers

Routine and emergency care.

Companion Animal Hospital in Ithaca, NY for cats, dogs, exotics, and wildlife

Equine and Nemo Farm Animal Hospitals in Ithaca, NY for horses and farm animals

Cornell Ruffian Equine Specialists, on Long Island for every horse

Ambulatory and Production Medicine for service on farms within 30 miles of Ithaca, NY

Animal Health Diagnostic Center New York State Veterinary Diagnostic Laboratory

General Information

Cornell University College of Veterinary Medicine Ithaca, New York 14853-6401

Cornell provides pet travel documentation amid changing U.S. requirements

Veterinarians at the Cornell Small Animal Community Practice are poised and ready to help would-be traveling pet owners no matter the requirements. Photo: Carol Jennings/CVM

The Centers for Disease Control (CDC) backtracked last month on strict requirements about dogs returning from international travel. In May, they announced a new process with differing rules depending on the source country, and limited pet owners to using only airports with proper quarantine facilities.

Just two weeks before the Aug. 1 deadline, however, the CDC amended its policy to a fraction of the proposed requirements — apparently in response to strong outcry from the public, veterinary professionals and airlines, all voicing concern over the feasibility of meeting such comprehensive criteria. Now, dogs arriving in the U.S. from countries with a low risk of rabies, such as Canada and the European Union, only need to be at least six months old with a microchip, and owners can submit a single form and attest to the animal’s health upon arrival.

All animals, not only dogs, must be assessed before leaving or entering the country. This assessment takes the form of an international health certificate (IHC), a document that states an animal has recently been examined and meets all the criteria for travel to another country, which can only be provided by USDA-certified veterinarians.

Veterinarians at the Cornell Small Animal Community Practice are poised and ready to help would-be traveling pet owners no matter the requirements. Dr. Michelle Porter is one of three veterinarians at the community practice certified by the USDA.

“The number of certificates that we have done over the past five years has exponentially grown,” Porter said. “We used to do one every few months, but I can think of at least 16 that we have done in the past three months alone.”

Why the increase? “It is becoming more common for owners to travel with their pets instead of leaving them behind in a kennel or with a pet sitter,” Porter said.

Dr. Korana Stipetic visited the Cornell Small Animal Community Practice in July to certify her pets for an upcoming trip to Europe — four dogs and two cats will be making the journey with her. “This is the first time I have used the service, and it has been amazing,” Stipetic said. She said that while she doesn’t travel often, it was important to be able to bring the pets with her. “They are my family.”

Obtaining an IHC is not always easy and can take multiple visits to a veterinarian. Porter notes that nearly all countries require animals be microchipped and up to date on their rabies vaccine. Other countries require a rabies titer, a blood test that ensures the animal has mounted a good response to the vaccine. Still others have additional requirements, but in general each country’s criteria are unique.

Stipetic describes her visit to the Cornell Small Animal Community Practice as easy and smooth, even with six animals to certify. “I shared with them the special needs for some of my animals. I have several senior animals, and a few very frightened animals,” she said. “They guided me through the whole process, so that it was clear at each point what needed to happen, and my animals were taken care of in the way that made me feel that we were all safe, listened to and supported.”

Europe, where Stipetic will be traveling, has become stricter with their rabies vaccine standards in recent years. Veterinarians like Porter at the community practice keep abreast of evolving requirements, as Cornell has offered this service to its own community and the surrounding area for many years.

  “Cornell has a very diverse population, with students and staff coming from all over the world,” Porter said. “A lot of international travel happens and so we need to be sure that there is an easy way for Cornellians to travel home with their pets.”

To ease the way for furry globetrotters, Porter advises that owners plan ahead. “We recommend starting the planning process between two and six months prior to travel, depending on location,” she said. Not every veterinary clinic has a UDSA-certified veterinarian, and in some places it can take weeks to get in for an initial consult and still more time for certain test results.

The CDC keeps its requirements up to date on its website . The USDA’s resource list for owners provides the requirements for each country, and pet owners can find a certified veterinarian on its database .

For now, Stipetic and her animals are ready for their trip. “The whole Cornell team — from the front desk, to students, techs and veterinarians — listened to our needs, met them and simply made it happen in a most gentle and kind way,” she said. “I am very grateful and still cannot believe how smoothly everything went!”

Written by Melanie Greaver Cordova

Recent News

USA Today: Why does my cat keep throwing up? Advice from an expert

Cornell Feline Health Center adds to legacy at 36th annual Fred Scott Feline Symposium

Teaching dairy seminar, "veterinary medicine across the pond, not oceans apart" by dr. steven van winden, seminars in infection & immunity (vetmi 7120) -- dr. rebecca dubois, seminars in infection & immunity (vetmi 7120) -- dr. adam braunschweig, seminars in infection & immunity (vetmi 7120) -- dr. stavroula hatzios.

• Message from the Chair
• Faculty & Staff Resources
• Diversity, Equity and Inclusion
• Recruitment
• How To Apply
• Coming for an Interview?
• Living in Tucson
• Facts & Figures
• Accolades & Awards
• Photo Galleries
• Media Mentions
• DOM News Archive
• Maps & Directions
• Ways to Give
• Dermatology
• Endocrinology
• Gastroenterology and Hepatology
• General Internal Medicine, Geriatrics and Palliative Medicine
• Hematology and Oncology
• Infectious Diseases
• Inpatient Medicine
• Pulmonary, Allergy, Critical Care and Sleep Medicine
• Rheumatology
• Message from the Vice Chair
• Medical Student Education
• Residency Programs
• Fellowships
• Applicant Recruitment Notice
• Where We Teach And Train
• Core & Key Clinical Faculty Guide
• Tools for Teaching
• Academic Activity Log
• Teaching Resources
• Statistical Support Initial Request Form
• Proteomics Lab
• Featured Spotlights
• Researcher Spotlights
• Research Projects
• DOM Research Seminar Series
• Publications
• Top Doctors In The News
• DOM Blog Posts
• Where We Practice
• UA Arthritis Center
• UA Asthma & Airway Disease Research Center
• UA Cancer Center
• UA Center on Aging
• UA Center for Applied Genetics & Genomic Medicine
• UA Center for Biomedical Informatics & Biostatistics
• UA Center for Disparities in Diabetes, Obesity & Metabolism
• UA Center for Integrative Medicine
• UA Center for Sleep, Circadian & Neuroscience Research
• UA Petersen HIV Clinics
• Pacific AIDS Education & Training Center – Arizona
• UA Sarver Heart Center
• UA Skin Cancer Institute
• UA Thomas D. Boyer Liver Institute
• UA Valley Fever Center for Excellence

You are here

Envenomations, intoxications and travel-related diseases: more common than you think what to do about scorpions.

Arizona Telemedicine Program and Southwest Telehealth Resource Center present:

When | Noon to 1 p.m., Aug. 21, 2024 Where | Virtual

REGISTER HERE TO JOIN VIRTUALLY

Event Description

The practice and delivery of health care is changing with an emphasis on improving quality, safety, efficiency and access to care. Telemedicine can help you achieve these goals! The Arizona Telemedicine Program and Southwest Telehealth Resource Center invite you to a free one-hour CME webinar on the implementation and practice of telemedicine.

Envenomations, intoxications and travel-related diseases: More common than you think! What to do

Join us again in our series on envenomations, intoxications and bites in the Southwest. This session will be about scorpions, and not the rock band type! These critters are not insects, but are arachnids and are very common here in our desert environment. As an opportunistic predator, they can pack a painful punch!

This webinar is made possible through funding provided by Health Resources and Services Administration, Office for the Advancement of Telehealth (U1U42527).

Presenter Details

Farshad "Mazda" Shirazi, MS, MD, PhD Medical Director of Arizona Poison and Drug Information Center Professor, Emergency Medicine, Pharmacology and Pharmacy Practice Director of Medical Toxicology Fellowship University of Arizona Read more

Facilitator Details

Stephen Klotz, MD Professor, Family and Community Medicine Medical Director, Arizona Telemedicine Program University of Arizona Read more

Outcome Objectives

• Describe the epidemiology of scorpion stings.
• List three clinical presentations of the presented venom and allergic reactions. 
• Describe the treatment for symptoms from scorpion stings.

Accreditation Statement The University of Arizona College of Medicine – Tucson is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.

The University of Arizona College of Medicine – Tucson designates this live activity for a maximum of 1.0 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Relevant Financial Relationships Statement(s): University of Arizona College of Medicine – Tucson Office of Continuing Medical Education adheres to the ACCME's Standards for Integrity and Independence in Accredited Continuing Education. Any individuals in a position to control the content of a CME activity, including faculty, planners, reviewers or others are required to disclose all financial relationships with ineligible entities (commercial interests). The CME office reviewers have nothing to disclose. All relevant financial relationships have been mitigated prior to the commencement of the activity.

Audience: College of Health Sciences College of Medicine – Phoenix College of Medicine – Tucson College of Nursing Mel and Enid Zuckerman College of Public Health R. Ken Coit College of Pharmacy

Contacts: Melanie Esher, MAdm [email protected] 520-626-6103

LSHTM LSHTM Research Online

Providing travel medicine advice to visiting friends and relatives travellers: high risk and difficult to advise.

Copy to clipboard Copy Stauffer, WM ; Behrens, RH ; (2005) Providing travel medicine advice to visiting friends and relatives travellers: high risk and difficult to advise. Clinics in Family Practice, 7 (4) (4). pp. 717-729. ISSN 1522-5720 https://researchonline.lshtm.ac.uk/id/eprint/9379

Permanent Identifier

Use this permanent URL when citing or linking to this resource.

Copy to clipboard Copy https://researchonline.lshtm.ac.uk/id/eprint/9379

UNSPECIFIED

Additional Information

View details

Google Scholar